Cargando…
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths attributable to delays in source control and/or the introduction of antifungal therapy. Currently, there is no compr...
Autores principales: | Novy, Emmanuel, Roger, Claire, Roberts, Jason A., Cotta, Menino Osbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659066/ https://www.ncbi.nlm.nih.gov/pubmed/37981676 http://dx.doi.org/10.1186/s13054-023-04742-w |
Ejemplares similares
-
Reappraisal of intra-abdominal candidiasis: insights from peritoneal fluid analysis
por: Novy, Emmanuel, et al.
Publicado: (2023) -
A Systematic Review on Antimicrobial Pharmacokinetic Differences between Asian and Non-Asian Adult Populations
por: Setiawan, Eko, et al.
Publicado: (2023) -
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
por: do Couto, Fabíola Maria Marques, et al.
Publicado: (2016) -
Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
por: Vergidis, Pascalis, et al.
Publicado: (2016) -
We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
por: Cotta, Menino Osbert, et al.
Publicado: (2016)